SI
CLB icon

Stephens Inc’s Core Laboratories CLB Stock Holding History

Stephens Inc’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-3,451
Closed -$130K – 1127
2019
Q4 		$130K Sell
3,451
-3,497
-50% -$157K ﹤0.01% 1047
2019
Q3 		$324K Buy
6,948
+3,059
+79% +$142K 0.01% 880
2019
Q2 		$203K Sell
3,889
-227
-6% -$13.3K ﹤0.01% 1062
2019
Q1 		$284K Sell
4,116
-68
-2% -$4.56K 0.01% 934
2018
Q4 		$250K Buy
4,184
+599
+17% +$51.7K 0.01% 913
2018
Q3 		$415K Buy
3,585
+34
+1% +$3.84K 0.01% 836
2018
Q2 		$448K Hold
3,551
– – 0.01% 630
2018
Q1 		$384K Buy
3,551
+28
+0.8% +$3.1K 0.01% 537
2017
Q4 		$386K Buy
3,523
+827
+31% +$82.5K 0.01% 529
2017
Q3 		$266K Sell
2,696
-356
-12% -$34.5K 0.01% 604
2017
Q2 		$309K Buy
3,052
+6
+0.2% +$647 0.01% 684
2017
Q1 		$352K Buy
3,046
+31
+1% +$3.6K 0.01% 630
2016
Q4 		$362K Sell
3,015
-95
-3% -$10.5K 0.01% 566
2016
Q3 		$349K Hold
3,110
– – 0.02% 583
2016
Q2 		$385K Buy
3,110
+705
+29% +$85.1K 0.02% 542
2016
Q1 		$270K Sell
2,405
-111
-4% -$11.5K 0.01% 564
2015
Q4 		$274K Buy
2,516
+15
+0.6% +$1.72K 0.01% 562
2015
Q3 		$250K Sell
2,501
-1,001
-29% -$109K 0.01% 591
2015
Q2 		$399K Buy
3,502
+27
+0.8% +$3.27K 0.02% 544
2015
Q1 		$363K Buy
3,475
+22
+0.6% +$2.34K 0.02% 567
2014
Q4 		$416K Sell
3,453
-263
-7% -$34.5K 0.02% 541
2014
Q3 		$544K Buy
3,716
+94
+3% +$14.5K 0.03% 470
2014
Q2 		$605K Buy
3,622
+202
+6% +$35.9K 0.03% 446
2014
Q1 		$679K Buy
3,420
+231
+7% +$43.6K 0.04% 403
2013
Q4 		$609K Buy
3,189
+20
+0.6% +$3.72K 0.03% 453
2013
Q3 		$536K Buy
3,169
+1,580
+99% +$245K 0.03% 448
2013
Q2 		$241K Buy
+1,589
New +$225K 0.01% 591

Other funds holding CLB

VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
MPI
Mairs & Power Inc St Paul, Minnesota $10.9B AUM 27.5% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Stephens Inc's CLB Position: Q1 2020 in Review

Stephens Inc sold out of Core Laboratories (CLB) in Q1 2020, closing a stake of 3,451 shares — an estimated $130K sold.

Stephens Inc first reported a position in CLB in Q2 2013 and held it in 27 quarters. The position peaked at $679K in Q1 2014. 207 funds tracked by Wall St. Rank hold CLB as of Q1 2020.

  • Stephens Inc reported no remaining Core Laboratories position as of Q1 2020 after selling out during the quarter.
  • Stephens Inc sold 3,451 Core Laboratories shares in Q1 2020, an estimated $130K.
  • Stephens Inc first reported a position in Core Laboratories in Q2 2013 and held it in 27 quarters.
  • Stephens Inc's Core Laboratories position peaked at $679K in Q1 2014.
  • 207 funds tracked by Wall St. Rank held Core Laboratories as of Q1 2020.

Based on Stephens Inc's 13F filing for Q1 2020, filed 14 May 2020.